Profiel
Dominique Thomas is the founder of Cytomics Pharmaceuticals SA and Alderys SAS, which was founded in 2000 and 2010 respectively.
At Alderys SAS, she holds the title of Chairman, CEO & Scientific Director.
Dr. Thomas holds a doctorate degree from Université Pierre et Marie Curie.
Actieve functies van Dominique Thomas
| Bedrijven | Functie | Begin |
|---|---|---|
Alderys SAS
 Alderys SAS BiotechnologyHealth Technology Alderys SAS engage in the development of approaches to the micro-organic biological engineering of profitable chemical compounds from renewable plant resources. It operates in the following markets: chemicals for generating building block compounds, animal nutrition, and cosmetics. The company was founded by Dominique Thomas on July 30, 2010 and is headquartered in Orsay, France. | Oprichter | 30-07-2010 |
Eerdere bekende functies van Dominique Thomas
| Bedrijven | Functie | Einde |
|---|---|---|
Cytomics Pharmaceuticals SA
 Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cytomics Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs that control the degradation of proteins, to treat major human diseases. The company was founded in April 2000 in collaboration with Dominique Thomas (Research Director at the Center for Molecular Genetics of the CNRS) and Richard Benarous (Director of the Department for Infectious Diseases 'at the Cochin Institute of Molecular Genetics), both specialists recognized by the ubiquitin-proteasome protein degradation. | Oprichter | 10-10-2011 |
Opleiding van Dominique Thomas
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Cytomics Pharmaceuticals SA
Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cytomics Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs that control the degradation of proteins, to treat major human diseases. The company was founded in April 2000 in collaboration with Dominique Thomas (Research Director at the Center for Molecular Genetics of the CNRS) and Richard Benarous (Director of the Department for Infectious Diseases 'at the Cochin Institute of Molecular Genetics), both specialists recognized by the ubiquitin-proteasome protein degradation. | Health Technology |
| Université Pierre et Marie Curie | Consumer Services |
Alderys SAS
Alderys SAS BiotechnologyHealth Technology Alderys SAS engage in the development of approaches to the micro-organic biological engineering of profitable chemical compounds from renewable plant resources. It operates in the following markets: chemicals for generating building block compounds, animal nutrition, and cosmetics. The company was founded by Dominique Thomas on July 30, 2010 and is headquartered in Orsay, France. | Health Technology |
